A platform developed by NeuraLight that uses machine learning to measure eye movements may help track the progression of…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
Researchers have developed a new tool, called RETFound, to analyze images of the eyes using artificial intelligence (AI). The scientists…
An ethics committee in Australia has cleared Gain Therapeutics to start a Phase 1 clinical trial testing GT-02287, the…
The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has awarded a $4.5 million grant to Nine Square…
People with Parkinson’s disease commonly experience stigma associated with the disorder, and if clinicians are to provide proper care…
A treatment that works to stimulate the brain using weak magnetic waves effectively eased symptoms in a mouse model of…
People with Parkinson’s disease who have more severe nonmotor symptoms are less likely to feel empowered to manage their…
People with a specific variation in a gene that helps control the immune system are less likely to develop…
A mutation in the GBA1 gene is associated with an increased risk of Parkinson’s disease among people of African ancestry,…
ND0612, a formulation of levodopa/carbidopa delivered continuously under the skin by a pump, was more effective than…